Sector BioCryst Pharmaceuticals, Inc.

Aandelen

BCRX

US09058V1035

Biotechnologie & Medisch Onderzoek

Geschatte realtime 20:48:34 28-10-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
8,315 USD +2,65% Intraday-grafiek van BioCryst Pharmaceuticals, Inc. +6,77% +6,09%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
+2,65%+6,77%-2,30%-15,04%+6,09%+14,30%+50,73%-45,70%+101,34% 2,07 mld.
+0,65%-3,56%-12,32%+14,23%+57,11%+33,53%+60,50%+5,04% - 63,48 mld.
+1,76%+1,27%-5,68%+3,19%+11,13%+11,82%+82,12%+231,09%+5.462,85% 54,55 mld.
-0,94%+0,99%+7,81%+12,42%+17,11%+10,45%+102,18%-17,00%+234,11% 53,59 mld.
+2,68%+0,25%+2,34%+14,15%+23,02%+27,13%+56,53%+7,82%+286,39% 44,75 mld.
+2,26%-3,13%+2,01%+13,28%+23,22%+18,15%+100,61%+2,68%+1.018,49% 41,62 mld.
+1,09%-3,32%-6,90%+2,16%+135,82%+222,90%+923,60%+531,36% - 39,91 mld.
+0,64%-3,85%+6,99%+6,21%+10,10%+11,71%+45,57%+5,41%+152,66% 32,47 mld.
+29,06%+47,63%+68,03%+102,73%+90,82%+107,12%+94,27%+36,25%+242,30% 26,7 mld.
+3,72%-7,45%-12,60%+19,81%+47,33%+24,25%-2,99%-60,58% - 23,36 mld.
+1,21%-4,03%-11,58%-5,24%-7,97%-16,59%-6,05%-69,15% - 21,87 mld.
+2,91%+3,46%-17,32%-6,56%-44,10%-41,14%+308,80%+228,81%+618,57% 20,74 mld.
+2,41%+3,95%+11,81%+20,61%+22,61%+18,63%+184,81%+213,44%+2.283,73% 18,85 mld.
+4,50%+8,26%+26,74%+55,28%+87,16%+98,66%+126,93%-14,91%+391,25% 17,13 mld.
+0,89%+6,60%+9,55%+25,86%+38,21%+41,38%+84,55%-16,19%+110,21% 16,53 mld.
+1,16%+2,59%+13,50%+17,24%+51,15%+65,32%+227,32%+204,46%+508,92% 16,19 mld.
+1,41%+4,49%+8,51%-1,89% - - - - - 16,15 mld.
+0,84%+3,90%+3,90%+0,42%+183,22%+163,59%+345,61%+1.418,19%+787,21% 15,21 mld.
-4,32%-7,35%-7,15%-15,56%+10,56%+0,93%+463,48% - - 13,81 mld.
+13,68%+10,85%+16,96%+13,93%+12,69%+15,54%-13,77%-28,31%+155,66% 14,12 mld.
Gemiddelde +3,37%+1,77%+5,11%+13,86%+40,80%+43,56%+170,25%+146,26%+882,41% 27,65 mld.
Gewogen gemiddelde per kap. +2,93%+0,90%+3,19%+14,72%+40,67%+43,44%+167,39%+123,35%+1.239,39%
  1. Beurs
  2. Aandelen
  3. Koers BCRX
  4. Sector BioCryst Pharmaceuticals, Inc.